CIK: 0001822947 · Show all filings
Period: Q3 2022 (← Previous) (Next →)
Filing Date: Nov 14, 2022
Total Value ($000): $151,465 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | SEAGEN INC | 92,506 | $12,658 | 8.4% | $136.83 | — | COM | 81181C104 |
| RARE | ULTRAGENYX PHARMACEUTICAL IN | 217,075 | $8,989 | 5.9% | $51.39 | 0.0% | COM | 90400D108 |
| SNY | SANOFI | 230,000 | $8,745 | 5.8% | $38.02 | — | SPONSORED ADR | 80105N105 |
| — | KARYOPHARM THERAPEUTICS INC | 1,528,580 | $8,346 | 5.5% | $5.46 | — | COM | 48576U106 |
| IRWD | IRONWOOD PHARMACEUTICALS INC | 742,570 | $7,693 | 5.1% | $11.34 | 0.0% | COM CL A | 46333X108 |
| RCKT | ROCKET PHARMACEUTICALS INC | 479,506 | $7,653 | 5.1% | $15.60 | 0.0% | COM | 77313F106 |
| GSK | GSK PLC | 255,000 | $7,505 | 5.0% | $29.43 | — | SPONSORED ADR | 37733W204 |
| — | AMARIN CORP PLC | 6,358,288 | $6,931 | 4.6% | $1.09 | — | SPONS ADR NEW | 023111206 |
| ALKS | ALKERMES PLC | 300,000 | $6,699 | 4.4% | $26.01 | 0.0% | SHS | G01767105 |
| — | MERSANA THERAPEUTICS INC | 931,539 | $6,297 | 4.2% | $6.76 | — | COM | 59045L106 |
| SYRS | SYROS PHARMACEUTICALS INC | 868,403 | $5,593 | 3.7% | $8.12 | 0.0% | COM NEW | 87184Q206 |
| — | HORIZON THERAPEUTICS PUB L | 74,262 | $4,596 | 3.0% | $61.89 | — | SHS | G46188101 |
| — | MEDAVAIL HOLDINGS INC | 5,894,897 | $4,574 | 3.0% | $8.23 | — | COM | 58406B103 |
| GOSS | GOSSAMER BIO INC | 377,000 | $4,516 | 3.0% | $8.34 | +48.8% | COM | 38341P102 |
| SANA | SANA BIOTECHNOLOGY INC | 735,250 | $4,412 | 2.9% | $7.22 | 0.0% | COM | 799566104 |
| ARGX | ARGENX SE | 12,240 | $4,321 | 2.9% | $378.89 | — | SPONSORED ADR | 04016X101 |
| — | SAGE THERAPEUTICS INC | 110,222 | $4,316 | 2.8% | $39.16 | — | COM | 78667J108 |
| — | ALLAKOS INC | 598,172 | $3,661 | 2.4% | $6.12 | — | COM | 01671P100 |
| — | ADICET BIO INC | 244,400 | $3,475 | 2.3% | $14.22 | — | COM | 007002108 |
| GLPG | GALAPAGOS NV | 76,489 | $3,261 | 2.2% | $42.63 | — | SPON ADR | 36315X101 |
| RGEN | REPLIGEN CORP | 16,724 | $3,129 | 2.1% | $210.87 | 0.0% | COM | 759916109 |
| COGT | COGENT BIOSCIENCES INC | 204,014 | $3,044 | 2.0% | $10.99 | +24.8% | COM | 19240Q201 |
| — | ISOPLEXIS CORP | 1,522,364 | $2,618 | 1.7% | $9.19 | — | COM | 465005106 |
| RPID | RAPID MICRO BIOSYSTEMS INC | 699,664 | $2,260 | 1.5% | $15.69 | -75.3% | CLASS A COM | 75340L104 |
| AVIR | ATEA PHARMACEUTICALS INC | 360,000 | $2,048 | 1.4% | $7.65 | 0.0% | COM | 04683R106 |
| — | SCIENCE 37 HOLDINGS INC | 1,266,512 | $2,039 | 1.3% | $2.01 | — | COM | 808644108 |
| WHWK | AADI BIOSCIENCE INC | 124,625 | $1,761 | 1.2% | $13.14 | 0.0% | COM | 00032Q104 |
| NAUT | NAUTILUS BIOTECHNOLOGY INC | 823,974 | $1,747 | 1.2% | $10.83 | -76.8% | COM | 63909J108 |
| INCY | INCYTE CORP | 25,000 | $1,666 | 1.1% | $73.88 | 0.0% | COM | 45337C102 |
| — | INTERCEPT PHARMACEUTICALS IN | 100,000 | $1,395 | 0.9% | $13.95 | — | COM | 45845P108 |
| — | NEKTAR THERAPEUTICS | 432,952 | $1,385 | 0.9% | $3.20 | — | COM | 640268108 |
| — | VOR BIOPHARMA INC | 255,162 | $1,016 | 0.7% | $3.98 | — | COM | 929033108 |
| EDIT | EDITAS MEDICINE INC | 82,900 | $1,015 | 0.7% | $15.58 | 0.0% | COM | 28106W103 |
| — | CLOVIS ONCOLOGY INC | 533,501 | $635 | 0.4% | $1.19 | — | COM | 189464100 |
| — | SELECTA BIOSCIENCES INC | 334,255 | $548 | 0.4% | $1.64 | — | COM | 816212104 |
| — | MORPHOSYS AG | 95,031 | $478 | 0.3% | $5.03 | — | SPONSORED ADS | 617760202 |
| — | CURIS INC | 264,023 | $185 | 0.1% | $0.70 | — | COM NEW | 231269200 |
| PBYI | PUMA BIOTECHNOLOGY INC | 64,295 | $152 | 0.1% | $2.92 | 0.0% | COM | 74587V107 |
| INFIQ | INFINITY PHARMACEUTICALS INC | 86,242 | $103 | 0.1% | $1.08 | 0.0% | COM | 45665G303 |